Buy Lupin, target Rs 820: Kunal Bothra
Buy Lupin Ltd. at a price target of Rs 820.0 and a stoploss at Rs 775 from entry point.

Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9680.25 Crore to Sales Value (95.95 % of Total Sales), Export Incentives which contributed Rs 223.88 Crore to Sales Value (2.21 % of Total Sales), Other Services which contributed Rs 173.65 Crore to Sales Value (1.72 % of Total Sales) and Other Operating Revenue which contributed Rs 10.40 Crore to Sales Value (0.10 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 4377.94 Crore, up 12.52 % from last quarter Sales of Rs 3890.93 Crore and up 12.24 % from last year same quarter Sales of Rs 3900.36 Crore Company has reported net profit after tax of Rs -153.59 Crore in latest quarter. The company’s top management includes Dr.K U Mada, Dr.Kamal K Sharma, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Deshbandhu Gupta, Mr.R A Shah, Mr.Richard Zahn, Mrs.Manju D Gupta, Ms.Vinita Gupta. Company has B S R & Co. LLP as its auditoRs As on 31-12-2018, the company has a total of 452,405,376 shares outstanding.
Download ET Markets APP